Regeneron Pharmaceuticals | REGN - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 17.4B 410M 2026-09
Agenus USD 33.7M 500K 2026-03
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amgen USD 10.4B 300M 2026-09
Astellas Pharma JPY 629.95B 10.96B 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 268M 22M 2026-06
J&J USD 25.4B 89M 2026-09
Kyowa Hakko Kirin JPY 121.3B 23.86B 2026-09
Merck USD 18.1B 1.5B 2026-09
Moderna USD 100M 289M 2026-06
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
Novartis USD 15.03B 1.92B 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 12.3B 160M 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Teva Pharmaceutical Industries USD 4.37B 8.3B 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
United Therapeutics USD 832.5M 49.2M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09